A recombinant vaccine is described which is composed of one recombinant protein comprising F1 and V antigen of Yersinia pestis. This vaccine protects experimental mice against pneumonic as well as bubonic plague produced by either F1.sup.+ or F1.sup.- strains of Y. pestis and may provide the basis for an improved human plague vaccine.